Your search for non small cell lung cancer returned 491 results

Your search for non small cell lung cancer returned 491 results

Sort Results:

Relevant Recent
News

FDA Approves Tagrisso to Treat Non-Small Cell Lung Cancer

The US Food and Drug Administration (FDA) has approved Tagrisso (osimertinib; AstraZeneca) for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
News

Atezolizumab vs. Docetaxel Survival Time Assessed for NSCLC

The immunotherapy atezolizumab extends the survival of previously treated non-small-cell lung cancer patients for several months and causes fewer side effects than docetaxel, according to a study published online in The Lancet.